Direktorat Registrasi ObatValid

IMATINIB MESILATE

BPOM Number: GKL2636707817A1
Approved: 23 September 2026
Expiry: 22 September 2031
Form: TABLET SALUT SELAPUT

About This Registration

IMATINIB MESILATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2636707817A1. Its current registration status is Valid, with the licence valid until 22 September 2031. The product is registered to SEJAHTERA LESTARI FARMA - INDONESIA. BPOM first approved this registration in September 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 24 September 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 6 BLISTER @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 24 September 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

SEJAHTERA LESTARI FARMA - INDONESIA
KAB. PASURUAN
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

SEJAHTERA LESTARI FARMA - INDONESIA
KAB. PASURUAN
primary
View profile →

Ingredients (1)

IMATINIB MESILATE

Market Intelligence

Owner Portfolio: SEJAHTERA LESTARI FARMA - INDONESIA holds 74 BPOM registrations
Manufacturer Scale: SEJAHTERA LESTARI FARMA - INDONESIA produces 74 registered products
Update Status: Recently updated (1 days ago)

FDA Cross-Reference

via openFDA

Generic Name: IMATINIB MESYLATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?